Boston Scientific Corp. is purchasing Axonics in a move the buyer says will allow it to pursue a ripe segment of the urology market. 

Geraldine McGinty, MD, Weill Cornell Medicine, explains how practices can retain radiologists during the Great Resignation in healthcare.

Both providers and payers upped their game on price transparency in 2023.

Private equity is becoming more and more influential in many healthcare specialties, including cardiology. This has prompted increased speculation about the impact such investments may have on patient outcomes.

Congress has already adjourned for the year without taking action, but U.S. medical societies are hoping relief from significant Medicare cuts will arrive in early 2024. 

What happens when hospitals en masse stock up on supplies to withstand a health crisis of unknown duration?

The company and one of its subsidiaries would allegedly confuse clinicians and have them bill government programs for cardiac monitoring services that were more expensive than what they needed. This settlement resolves those allegations. 

RBMA President-elect Pete Moffatt discusses how to contend with challenges such as staff shortages and reimbursement issues.